INMED PHARMACEUTICALS INC. Earnings Per Share (Basic)
INMED PHARMACEUTICALS INC. (INM) reported Earnings Per Share (Basic) of -$3.12 per share for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.73.
- INMED PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.51.
- INMED PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.44.
- INMED PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-03-31 was -$1.94.
- INMED PHARMACEUTICALS INC. earnings per share, basic for fiscal 2023 was -$3.25.
- INMED PHARMACEUTICALS INC. earnings per share, basic for fiscal 2022 was -$33.17.
- INMED PHARMACEUTICALS INC. earnings per share, basic for fiscal 2021 was -$37.96.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.12 S-4/A · filed 2026-09-09 | ||||||
| 2026-03-31 | -$0.73 S-4 · filed 2026-07-02 | -$1.69 S-4 · filed 2026-07-02 | |||||
| 2025-12-31 | -$0.51 10-Q · filed 2026-02-11 | -$0.95 10-Q · filed 2026-02-11 | |||||
| 2025-09-30 | -$0.44 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$8.36 S-4/A · filed 2026-09-09 | ||||||
| 2025-03-31 | -$1.94 S-4 · filed 2026-07-02 | -$7.93 S-4 · filed 2026-07-02 | |||||
| 2024-12-31 | -$3.64 10-Q · filed 2026-02-11 | -$6.43 10-Q · filed 2026-02-11 | |||||
| 2024-09-30 | -$2.71 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | -$20.14 S-4 · filed 2026-07-02 | -$1.01 10-K · filed 2024-09-30 | |||||
| 2024-03-31 | -$3.58 10-Q · filed 2025-05-12 | -$16.48 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | -$3.71 10-Q · filed 2025-02-12 | -$0.19 10-Q · filed 2024-02-13 | -$14.21 10-Q · filed 2025-02-12 | -$0.71 10-Q · filed 2024-02-13 | |||
| 2023-09-30 | -$15.24 10-Q · filed 2024-11-14 | -$0.76 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | -$3.25 10-K · filed 2024-09-30 | ||||||
| 2023-03-31 | -$0.60 10-Q · filed 2023-05-15 | -$3.53 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | -$0.91 10-Q · filed 2024-02-13 | -$3.54 10-Q · filed 2024-02-13 | |||||
| 2022-09-30 | -$4.06 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$33.17 10-K · filed 2023-09-29 | ||||||
| 2022-03-31 | -$6.14 10-Q · filed 2023-05-15 | -$20.13 10-Q · filed 2023-05-15 | |||||
| 2021-12-31 | -$7.73 10-Q · filed 2023-02-17 | -$14.03 10-Q · filed 2023-02-17 | |||||
| 2021-09-30 | -$6.17 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$37.96 10-K · filed 2022-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |